{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:03:28Z","timestamp":1784945008445,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ejphar.2024.177154","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T07:22:05Z","timestamp":1733124125000},"page":"177154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Illuminating the enigmatic pathogenesis of Kawasaki disease: Unveiling novel therapeutic avenues by targeting FCGR3B-S100A12 pathway"],"prefix":"10.1016","volume":"987","author":[{"given":"Meng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangfeng","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177154_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2024.177154_bib2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/art.40784","article-title":"Monocyte-derived interleukin-1beta as the driver of S100a12-induced sterile inflammatory activation of human coronary artery endothelial cells: implications for the pathogenesis of Kawasaki disease","volume":"71","author":"Armaroli","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejphar.2024.177154_bib3","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1161\/CIRCULATIONAHA.123.064734","article-title":"Single-cell meta-analysis of neutrophil activation in Kawasaki disease and multisystem inflammatory syndrome in children reveals potential shared immunological drivers","volume":"148","author":"Beltran","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.177154_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.624798","article-title":"Association between rs12037447, rs146732504, rs151078858, rs55723436, and rs6094136 Polymorphisms and Kawasaki disease in the population of polish children","volume":"9","author":"Buda","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ejphar.2024.177154_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103016","article-title":"Fc receptors gone wrong: a comprehensive review of their roles in autoimmune and inflammatory diseases","volume":"21","author":"Chalayer","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejphar.2024.177154_bib6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jamapsychiatry.2021.0005","article-title":"Association of antihypertensive drug target genes with psychiatric disorders: a mendelian randomization study","volume":"78","author":"Chauquet","year":"2021","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.ejphar.2024.177154_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrg2537","article-title":"Mapping complex disease traits with global gene expression","volume":"10","author":"Cookson","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejphar.2024.177154_bib8","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/bmj.330.7499.1076","article-title":"What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?","volume":"330","author":"Davey Smith","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2024.177154_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.inf.0000261196.79223.18","article-title":"Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004","volume":"26","author":"Du","year":"2007","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ejphar.2024.177154_bib10","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0140-6736(03)12986-8","article-title":"S100A12 (EN-RAGE) in monitoring Kawasaki disease","volume":"361","author":"Foell","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2024.177154_bib11","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.201209-1602OC","article-title":"Proinflammatory S100A12 can activate human monocytes via Toll-like receptor 4","volume":"187","author":"Foell","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2024.177154_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1365-2362.2001.00881.x","article-title":"Fcgamma receptors in autoimmune diseases","volume":"31","author":"Fossati","year":"2001","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2024.177154_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.autrev.2009.12.004","article-title":"Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin","volume":"9","author":"Galeotti","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejphar.2024.177154_bib14","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/pr.2012.27","article-title":"Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease","volume":"71","author":"Gong","year":"2012","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ejphar.2024.177154_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amjcard.2023.07.049","article-title":"Impact of intensive low-density lipoprotein cholesterol-lowering therapy on coronary artery plaques in acute coronary syndrome","volume":"204","author":"Hirai","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2024.177154_bib16","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jacc.2006.02.077","article-title":"Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease","volume":"48","author":"Hirono","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2024.177154_bib17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.177154_bib18","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","article-title":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients","volume":"94","author":"Kato","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.177154_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.06.027","article-title":"Calcium and zinc tune autoinflammatory Toll-like receptor 4 signaling by S100A12","volume":"142","author":"Kessel","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2024.177154_bib20","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/ng.981","article-title":"Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease","volume":"43","author":"Khor","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2024.177154_bib21","article-title":"Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.177154_bib22","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1084\/jem.171.4.1239","article-title":"The glycosyl phosphatidylinositol-linked Fc gamma RIIIPMN mediates transmembrane signaling events distinct from Fc gamma RII","volume":"171","author":"Kimberly","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2024.177154_bib23","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/ped.14326","article-title":"Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)","volume":"62","author":"Kobayashi","year":"2020","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ejphar.2024.177154_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2249.2007.03326.x","article-title":"Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease","volume":"148","author":"Kobayashi","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejphar.2024.177154_bib25","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejphar.2024.177154_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12016-020-08783-9","article-title":"Immunogenetics of Kawasaki disease","volume":"59","author":"Kumrah","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.ejphar.2024.177154_bib27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ng.2227","article-title":"Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis","volume":"44","author":"Lee","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2024.177154_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104543","article-title":"Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease","volume":"90","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejphar.2024.177154_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cjca.2017.12.009","article-title":"Epidemiology of Kawasaki disease in Canada 2004 to 2014: comparison of surveillance using administrative data vs periodic medical record review","volume":"34","author":"Manlhiot","year":"2018","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ejphar.2024.177154_bib30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/ped.14164","article-title":"Cumulative incidence of Kawasaki disease with cardiac sequelae in Japan","volume":"62","author":"Matsubara","year":"2020","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ejphar.2024.177154_bib31","doi-asserted-by":"crossref","unstructured":"McCrindle, B.W., Rowley, A.H., Newburger, J.W., Burns, J.C., Bolger, A.F., Gewitz, M., Baker, A.L., Jackson, M.A., Takahashi, M., Shah, P.B., Kobayashi, T., Wu, M.H., Saji, T.T., Pahl, E., American Heart Association Rheumatic Fever, E., Kawasaki Disease Committee of the Council on Cardiovascular Disease in the, Y., Council on, C., Stroke, N., Council on Cardiovascular, S.,Anesthesia, Council on, E., Prevention, 2017. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation 135, e927-e999. https:\/\/doi.org\/10.1161\/CIR.0000000000000484.","DOI":"10.1161\/CIR.0000000000000484"},{"key":"10.1016\/j.ejphar.2024.177154_bib32","first-page":"785","article-title":"Kawasaki disease. With particular emphasis on arterial lesions","volume":"41","author":"Naoe","year":"1991","journal-title":"Acta Pathol. Jpn."},{"key":"10.1016\/j.ejphar.2024.177154_bib33","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American heart association","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.177154_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2024.177154_bib35","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(15)00380-X","article-title":"Molecular mechanisms underlying variations in lung function: a systems genetics analysis","volume":"3","author":"Obeidat","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejphar.2024.177154_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ng.2220","article-title":"A genome-wide association study identifies three new risk loci for Kawasaki disease","volume":"44","author":"Onouchi","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2024.177154_bib37","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1442-200X.2012.03692.x","article-title":"Incidence of Kawasaki disease in northern European countries","volume":"54","author":"Salo","year":"2012","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ejphar.2024.177154_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1385\/IR:29:1-3:219","article-title":"Functional regulation of human neutrophil Fc gamma receptors","volume":"29","author":"Selvaraj","year":"2004","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ejphar.2024.177154_bib39","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/archdischild-2014-307536","article-title":"The epidemiology of Kawasaki disease: a global update","volume":"100","author":"Singh","year":"2015","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejphar.2024.177154_bib40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1442-200x.2005.02049.x","article-title":"Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease","volume":"47","author":"Takahashi","year":"2005","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ejphar.2024.177154_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpeds.2007.12.021","article-title":"Resistance to intravenous immunoglobulin in children with Kawasaki disease","volume":"153","author":"Tremoulet","year":"2008","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejphar.2024.177154_bib42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ahj.2013.10.025","article-title":"A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease","volume":"167","author":"Tsuda","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2024.177154_bib43","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/archdischild-2018-315087","article-title":"Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015","volume":"104","author":"Tulloh","year":"2019","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejphar.2024.177154_bib44","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"Vosa","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2024.177154_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","article-title":"Global epidemiology of vasculitis","volume":"18","author":"Watts","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ejphar.2024.177154_bib46","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2024.177154_bib47","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1002\/art.23042","article-title":"Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12","volume":"56","author":"Wittkowski","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2024.177154_bib48","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2188\/jea.JE20190065","article-title":"Epidemiologic features of Kawasaki disease in Shanghai from 2013 through 2017","volume":"30","author":"Xie","year":"2020","journal-title":"J. Epidemiol."},{"key":"10.1016\/j.ejphar.2024.177154_bib49","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.amjcard.2004.05.076","article-title":"Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease","volume":"94","author":"Ye","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2024.177154_bib50","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2024.177154_bib51","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/ije\/dyab203","article-title":"Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease","volume":"50","author":"Zheng","year":"2022","journal-title":"Int. J. Epidemiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924008446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924008446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T17:06:39Z","timestamp":1735319199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924008446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"alternative-id":["S0014299924008446"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177154","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Illuminating the enigmatic pathogenesis of Kawasaki disease: Unveiling novel therapeutic avenues by targeting FCGR3B-S100A12 pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177154"}}